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The Use of a Molecular Probe to Investigate the Details of PriA Helicase Function
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Mutagenesis Assays
A docking simulation was run to find
likely 0207 binding sites. The amino
acid residues at these locations have
been altered to prevent 0207 binding.
Helicase assays will be used to see if
the mutant PriA proteins are resistant
to the inhibitor.
Abstract
During DNA replication in both eukaryotic and prokaryotic cells, the replication machinery (replisome)
invariably encounters structural DNA damage, an event that can result in disbanding of the replisome and the
creation of a collapsed replication fork. In order for DNA replication to continue, the replisome must be
reloaded onto the DNA strand, a process that often begins with unwinding of double-stranded DNA (dsDNA)
by the primosome protein PriA. Little is known about the mechanism through which PriA unwinds dsDNA
and begins replisome recruitment. We seek to shed new light on this mechanism through the use of a PriA
inhibitor, compound 0207. In our study, we attempt to determine the method of inhibition, the three-
dimensional structure of the PriA•0207 complex, and the 0207 binding site through steady-state kinetics
experiments, x-ray crystallography experiments, and mutagenesis assays. Data from the steady-state kinetics
titrations show that compound 0207 acts through a mixed mode of inhibition and binds to the PriA•ATP,
PriA•DNA, and PriA•ATP•DNA complexes with equal affinities. PriA crystals have been grown in the
presence of compound 0207 in an attempt to solve the three-dimensional structure of the PriA•0207 complex
using x-ray crystallography. Finally, a docking simulation based on steric interactions was used to identify
possible 0207 binding sites. To verify these results, single alanine substitutions of PriA were generated, each
with an alteration designed to inhibit the binding of compound 0207. With these results, we seek to provide a
more complete understanding of the interactions between PriA and compound 0207, which will contribute to
the overall goal of understanding the detailed mechanisms through which PriA catalyzes dsDNA unwinding to
initiate replication restart.
Goal
Helicases are incredibly small and dynamic protein machines that move at very high speeds while unwinding
DNA. This makes studying these proteins challenging. We are using a small molecule to “freeze” PriA in the
process of unwinding DNA, so that we can more easily study PriA’s DNA unwinding mechanism.
Compound 
0207
Conclusions
• Compound 0207 is an excellent inhibitor of PriA helicase activity.
• Compound 0207 binds to the PriA•ATP, PriA•DNA, and PriA•ATP•DNA complexes with equal affinities.
• Compound 0207 does not inhibit the helicase activity of PriA by directly competing with the binding of 
ATP or DNA.
• Therefore, compound 0207 is binding to PriA at a site separate from the ATP and DNA binding sites and 
could be inhibiting the helicase action of PriA by locking the protein in an intermediate conformation.
• Further investigating how compound 0207 inhibits PriA  helicase action could shed light on the mechanism 
of PriA catalyzed DNA unwinding.
Figure 1: Replication of the bacterial chromosome begins with helicase recruitment at the
origin. Replication proceeds along the circular chromosome in both directions until
replication is complete.
Figure 2: Often, the replication machinery (replisome) dissociates from the DNA, resulting in a collapsed
replication fork (represented by the stop sign). In order for DNA replication to continue, the replisome must
be reloaded back onto the chromosome. PriA serves as a key initiator of this pathway as it binds to the
collapsed fork and unwinds a portion of double-stranded DNA. The protein then recruits PriB and DnaT,
forming a complex that reloads the replisome onto the collapsed replication fork so DNA replication can
continue.
Figure 3: PriA initiates
replisome reloading by
unwinding a short
segment of DNA. PriA
changes conformations
at very high rates during
this process.
Figure 4: Compound 0207 is a small molecule
capable of inhibiting the helicase action of
PriA. Compound 0207 was identified using a
high throughput screen that scanned for
compounds able to inhibit the helicase activity of
PriA. This inhibitor is being used to lock PriA in
an intermediate conformation in order to better
study PriA’s helicase action.
Results
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Figure 6: Compound 0207
inhibits PriA with an IC50 of
2.8 µM. Helicase assays were
used to determine the IC50 of
compound 0207. PriA was
incubated with duplex DNA in
the presence of varying
concentrations of 0207, and the
fraction of double-stranded
DNA unwound by PriA was
measured.
Crystallography Experiments
Figure 7: Compound 0207 acts
through a mixed mode of
inhibition with respect to ATP
binding. ATPase assays were
used to determine the mode of
inhibition. PriA, single-stranded
DNA, and compound 0207
were incubated with varying
concentrations of ATP, and the
rate of ATP hydrolysis was
measured.
Figure 8: Compound 0207 acts
through a mixed mode of
inhibition with respect to DNA
binding. ATPase assays were
used to determine the mode of
inhibition. PriA, ATP, and
compound 0207 were incubated
with varying concentrations of
single-stranded DNA, and the
rate of ATP hydrolysis was
measured.
Figure 11 (right): Comparison of the apo
structure of PriA and the structure in the
presence of compound 0207. The apo
structure is shown in red and the 0207 PriA
structure in blue. The current model for PriA
crystals grown in the presence of compound
0207 does not exhibit any major structural
differences compared to the apo structure. The
RMSD for the backbone atoms is 0.594 Å.
Figure 12: PriA helicase structure
and possible 0207 binding sites.
ADP is shown as red sticks and
compound 0207 as green sticks. The
DNA binding-domain consists of the
winged helix domain (green) and the
3’ binding domain (red). The helicase
domain is made of helicase lobes 1
(blue) and 2 (orange), the Cys-rich
region (purple), and the C-terminal
domain (yellow). The aromatic rich
loop is shown in dark blue, the β-
hairpin in pink, and the ATP binding
site in light blue. Compound 0207 is
shown in the three most promising
binding sites.
0207 Dissociation Constants
Complex Kd value (µM)
PriA•ssDNA 16.6
PriA•ATP 15.9
PriA•ssDNA•ATP 18.0
Table 1:  Dissociation constants for 0207 
inhibition of PriA.  Compound 0207 acts through 
a mixed mode of inhibition with respect to both 
ATP and ssDNA binding and binds to the 
PriA•ssDNA, PriA•ATP, and PriA•ssDNA•ATP 
complexes with approximately equal affinities.
Compound 0207 does not bind to the ATP binding site of PriA
Compound 0207 does not bind to the DNA binding site of PriA
Crystallography Experiments
We have grown PriA crystals in the
presence of compound 0207. We hope
to find the three dimensional structure
of the PriA•0207 complex and are
currently refining the structure based on
the electron density maps generated
from our crystals. Unfortunately, there
is not yet any evidence of either
compound 0207 or ADP in the electron
density maps.
Figure 9: PriA crystals grown in the presence of compound 0207
Figure 10 (left): The PriA structure is built by fitting
atoms into the electron density maps. The electron
density maps were generated by passing an x-ray beam
through PriA crystals grown in the presence of compound
0207 and measuring the diffracted beams.
Compound 0207 inhibits PriA helicase activity with an IC50 of 2.8 µM
Figure 5: Helicase Assays were
used to indirectly measure the
fraction of DNA unwound
through fluorescence anisotropy.
The green circle represents the
fluorescein label, and the numbers
represent the number of base pairs
that comprise each oligonucleotide.
Background
